Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

May 31, 2016

Conditions
Acute Lymphoblastic Leukemia
Interventions
BIOLOGICAL

Blinatumomab

Administered by continuous intravenous infusion

Trial Locations (30)

1090

St. Anna Kinderspital, Vienna

10065

Memorial Sloan Kettering, New York

13353

Charité Campus Virchow Klinikum, Otto-Heubner-Centrum (OHC) für Kinder- und Jugendmedizin, Berlin

19104

Children's Hospital of Philadelphia, Philadelphia

20052

University of Milano-Bicocca, Hospital San Gerardo, Monza

25030

(CHU Besancon) Hopital Saint-Jaques, Besançon

30322

Children's Healthcare of Atlanta at Egleston, Atlanta

40225

Universitätsklinikum Düsseldorf, Düsseldorf

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

60590

Klinikum der Johann Wolfgang Goethe-Universität Frankfurt/Main, Frankfurt am Main

72076

Universitätsklinik für Kinder- und Jugendmedizin Tübingen, Tübingen

75935

Hopital Robert Debré (AP-HP), Paris

80045

Children's Hospital Denver, Aurora

80337

Klinikum der Universität München, Dr. von Haunersches Kinderspital, München

98105

Seattle Children's Hospital, Seattle

Unknown

Washington University, St Louis

Primary Children's Medical Center, Salt Lake City

Hôpital de la Timone (Enfants), Marseille

Universitätsklinikum Essen, Essen

Universitätsklinikum Hamburg-Eppendorf, Hamburg

Medizinische Hochschule Hannover, Hanover

Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel

Universitätsklinikum Würzburg, Würzburg

Dipartimento della Donna e del Bambino, Padua

38105-3678

St Jude Children's Research Hospital, Memphis

75390-9063

UT Southwestern Medical Center, Dallas

77030-2399

Texas Children's Cancer Center/ Baylor, Houston

M5G1X8

Hospital for Sick Children, Toronto

00165

The Bambino Gesù Children's Hospital, Rome

3015 GJ

Erasmus MC, Sophia Children's Hospital, Rotterdam

All Listed Sponsors
lead

Amgen Research (Munich) GmbH

INDUSTRY

NCT01471782 - Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia | Biotech Hunter | Biotech Hunter